Abbott Reports $1.5 Billion of Litigation Reserves Related to Ongoing Settlements for Depakote: AttorneyOne.com Provides Advice and Solutions for the Alleged Birth Defects from Depakote

Share Article

In Jan 25th 2012, Abbott Laboratories (the company manufacturing Depakote) reported that 2011 selling, general and administrative expense report includes $1.5 billion of litigation reserves related to ongoing settlement discussions in the investigation by the U.S. Department of Justice, through the U.S. Attorney for the Western District of Virginia, related to Depakote. Depakote is a drug most commonly prescribed for psychiatric conditions like manic depressive disorder (bipolar disorder) and to prevent migraine headaches. According to court documents, in Dec. 2010 and Jan. 2011 more than two dozen parents sued Abbott Laboratories (St. Clair County Circuit Court Case No.10-L-651, 11-L-27 & 11-L-143) claiming that Depakote caused birth defects in their children ranging from spina bifida to heart conditions. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal council so anyone can easily and inexpensively deal with cases of Depakote side effects. http://www.attorneyone.com/depakote/

Depakote severe birth defects threat

Depakote severe birth defects threat

the risk of spina bifida from Depakote may be 12 times higher with use of the medication during pregnancy

The media spotlight is often a double-edged sword. No one knows this better than the families of children with birth defects. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

According to the lawsuits filed in Dec. 2010 and Jan. 2011, more than two dozen parents sued Abbott Laboratories (St. Clair County Circuit Court Case No.10-L-651, 11-L-27 & 11-L-143) claiming that Depakote caused birth defects in their children ranging from spina bifida to heart conditions. This class action suit was the third class action filed in Illinois against Abbott Laboratories. These cases involve claims regarding pregnant mothers who used Depakote while pregnant.

On June 2010, the New England Journal of Medicine published a study mentioning that the risk of spina bifida from Depakote may be 12 times higher with use of the medication during pregnancy.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal council so that, in case of Depakote adverse effects, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat of severe adverse effects from Depakote remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

In October 2006, the FDA issued a "Black Box" warning on Depakote prescription, warning of instances of severe side side effects including teratogenicity, pancreatitis and hepatoxicity.

In late 2009, the FDA required Abbott Laboratories to update the warning label on Depakote to ensure that women of child-bearing age are aware of the risk of major birth defects.

AttorneyOne.com has further information on Depakote lawsuits including how to get in contact with legal council.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. Checkout earlier legal news from us at http://www.prweb.com/releases/2012/2/prweb9175558.htm.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Burke
Attorney One
1-877-230-7343
Email >
Visit website